Transcat, Inc. Forecasted to Post FY2025 Earnings of $2.31 Per Share (NASDAQ:TRNS)

Transcat, Inc. (NASDAQ:TRNS) – Research analysts at HC Wainwright decreased their FY2025 earnings per share estimates for shares of Transcat in a research note issued on Tuesday, April 16th. HC Wainwright analyst S. Buck now forecasts that the scientific and technical instruments company will earn $2.31 per share for the year, down from their previous estimate of $2.41. HC Wainwright currently has a “Buy” rating and a $124.00 target price on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.33 per share.

Other equities research analysts have also recently issued research reports about the company. Oppenheimer restated an “outperform” rating and issued a $125.00 price target (up previously from $120.00) on shares of Transcat in a research note on Thursday. TheStreet upgraded Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st.

Transcat Stock Up 2.7 %

TRNS opened at $108.04 on Thursday. Transcat has a 1-year low of $74.89 and a 1-year high of $115.41. The stock’s fifty day simple moving average is $108.50 and its 200 day simple moving average is $102.00. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01. The stock has a market cap of $953.89 million, a PE ratio of 83.11 and a beta of 0.59.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Monday, January 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. Transcat had a return on equity of 9.32% and a net margin of 4.16%. The company had revenue of $65.17 million during the quarter, compared to the consensus estimate of $63.36 million.

Institutional Trading of Transcat

Several large investors have recently modified their holdings of TRNS. Wasatch Advisors LP grew its holdings in shares of Transcat by 13.3% during the 4th quarter. Wasatch Advisors LP now owns 701,099 shares of the scientific and technical instruments company’s stock worth $76,651,000 after purchasing an additional 82,458 shares in the last quarter. Broadcrest Asset Management LLC grew its holdings in shares of Transcat by 17.6% during the 4th quarter. Broadcrest Asset Management LLC now owns 400,000 shares of the scientific and technical instruments company’s stock worth $43,732,000 after purchasing an additional 60,000 shares in the last quarter. Bank of America Corp DE grew its holdings in shares of Transcat by 184.9% during the 1st quarter. Bank of America Corp DE now owns 83,687 shares of the scientific and technical instruments company’s stock worth $6,790,000 after purchasing an additional 54,314 shares in the last quarter. Comerica Bank acquired a new stake in shares of Transcat during the 3rd quarter worth $5,221,000. Finally, Vanguard Group Inc. grew its holdings in shares of Transcat by 12.3% during the 4th quarter. Vanguard Group Inc. now owns 477,799 shares of the scientific and technical instruments company’s stock worth $52,238,000 after purchasing an additional 52,421 shares in the last quarter. 98.34% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Transcat news, Director Charles P. Hadeed sold 700 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $113.00, for a total transaction of $79,100.00. Following the transaction, the director now owns 22,678 shares in the company, valued at approximately $2,562,614. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Transcat news, CEO Lee D. Rudow sold 2,373 shares of the stock in a transaction on Saturday, March 30th. The stock was sold at an average price of $111.43, for a total transaction of $264,423.39. Following the transaction, the chief executive officer now owns 103,688 shares in the company, valued at approximately $11,553,953.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Charles P. Hadeed sold 700 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $113.00, for a total value of $79,100.00. Following the transaction, the director now owns 22,678 shares in the company, valued at approximately $2,562,614. The disclosure for this sale can be found here. Insiders have sold 8,073 shares of company stock worth $900,023 in the last 90 days. Company insiders own 4.20% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.